launching the first rapid molecular test for COVID-19

CEPHEID

Cepheid has built a legacy in bringing gold standard molecular testing close to patients with the rapid turnaround time necessary for slowing and preventing disease outbreaks. When COVID-19 struck, we supported Cepheid’s communications strategy, conducted exclusive media outreach, we tightly controlled its message while still securing positive coverage in top-tier publications.

Canale Communications ©2020